TABLE 1.
Clinical and demographic characteristics of 160 borderline resectable patients
| All Patients (%) |
Borderline Type
|
p | |||
|---|---|---|---|---|---|
| A | B | C | |||
|
| |||||
| Total No. of Patients | 160 | 84 | 44 | 32 | |
|
| |||||
| Age (Years) | |||||
| Median (Mean) | 63 (63) | 60 (61) | 61 (61) | 73 (71) | 0.001 |
| Range | 36 – 90 | 37 – 81 | 36 – 77 | 50 – 90 | |
|
| |||||
| Gender | NS | ||||
| Male | 84 (52) | 37 (44) | 26 (59) | 21 (66) | |
| Female | 76 (48) | 47 (56) | 18 (41) | 11 (34) | |
|
| |||||
| Tumor Location | NS | ||||
| Head/Uncinate | 142 (89) | 73 (87) | 40 (91) | 29 (91) | |
| Body/Tail | 18 (11) | 11 (13) | 4 (9) | 3 (9) | |
|
| |||||
| Pre-referral Laparotomy | 0.001 | ||||
| Bypass | 31 (19) | 12 (14) | 16 (36) | 3 (9) | 0.003 |
| Exploration only | 7 (4) | 4 (5) | 3 (7) | 0 (0) | NS |
|
| |||||
| Pre-referral Therapy | 12 (8) | 7 (8) | 5 (11) | 0 (0) | NS |
| Systemic Chemotherapy | 6 (4) | 3 (4) | 3 (7) | 0 (0) | NS |
| External-beam Radiation | 7 (4) | 5 (6) | 2 (5) | 0 (0) | NS |
|
| |||||
| Pre-treatment CA19-9 (U/ml) | |||||
| All patients | |||||
| Median (Mean) | 203 (778) | 171 (728) | 266 (871) | 324 (767) | NS |
| Range | 2.3 – 11482 | 2.3 – 11482 | 3 – 7194 | 13 – 3787 | |
|
| |||||
| Patients who underwent pancreatectomy | |||||
| Median (Mean) | 207 (877) | 82 (974) | 21 (755) | 324 (830) | NS |
| Range | 9 – 11482 | 19 – 11482 | 9 – 7194 | 32 – 2797 | |
|
| |||||
| Patients who did not undergo pancreatectomy | |||||
| Median (Mean) | 203 (699) | 187 (551) | 323 (993) | 268 (730) | NS |
| Range | 2 – 6725 | 2 – 6725 | 3 – 3996 | 13 – 3787 | |
|
| |||||
| Underwent Pancreatectomy | |||||
| Yes | 66 (41) | 32 (38) | 22 (50) | 12 (38) | NS |
| No | 94 (59) | 52 (62) | 22 (50) | 20 (62) | |